[ Thymox Technology raises $4.6M in Series B ]
Thymox Technology has raised $4.6 million in Series B funding.
Founded in 2003, Laboratoire M2 has a well-respected reputation for product innovation and expertise in environmentally sustainable, green disinfection and bio-security technology under the trademark THYMOX™. Its line of animal health products includes THYMOX HOOF® which is used on dairy cows as an aid to control digital dermatitis (DD). THYMOX™ also distributes products and ingredients under private label agreements in institutional, retail, and crop protection markets.
The funds will primarily be used to accelerate international commercial expansion of THYMOX™ as a disinfectant for animal health and crop protection, and into institutional and retail markets.
|Founder / CEO||Frank Palantoni|